thiazoles has been researched along with neuropeptide y in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (28.57) | 18.2507 |
2000's | 8 (57.14) | 29.6817 |
2010's | 2 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cunningham, AM; Hipkiss, AR; Mayer, S; Michaelis, J; Müller, R; Münch, G; Neumann, A; Riederer, P; Schinzel, R | 1 |
Bing, C; Buckingham, R; Dryden, S; Frankish, HM; Hopkins, D; Pickavance, L; Wang, Q; Williams, G | 1 |
Alonso, R; Arnone, M; Bignon, E; Boigegrain, R; Brodin, R; Gueudet, C; Héaulme, M; Keane, P; Landi, M; Le Fur, G; Maffrand, JP; Molimard, JC; Olliero, D; Pascal, M; Poncelet, M; Seban, E; Simiand, J; Soubrié, P | 1 |
Fukami, T; Fukuroda, T; Hata, M; Ihara, M; Ishihara, A; Kanatani, A; Kanno, T; Mase, T; Sakuraba, A; Tanaka, T; Tsuchiya, Y | 1 |
Gruenewald, DA; Marck, BT; Matsumoto, AM; Naai, MA; Wolden-Hanson, T | 1 |
Buckingham, RE; Pickavance, LC; Wilding, JP | 1 |
Marck, BT; Matsumoto, AM; Wolden-Hanson, T | 1 |
Li, M; Lin, Y; Ma, Y; Zheng, Z | 1 |
Beck-Sickinger, A; Demuth, H; Dimitrijević, M; Kovacević-Jovanović, V; Stanojević, S; von Hörsten, S; Vujić, V | 1 |
Dautzenberg, FM; Guba, W; Higelin, J; Neidhart, W; Pflieger, P | 1 |
Demuth, HU; Li, L; Zukowska, Z | 1 |
Adams-Deutsch, T; Heilig, M; Nair, SG; Navarre, BM; Pickens, CL; Shaham, Y | 1 |
Irwin, CR; Killough, SA; Lundy, FT | 1 |
Davies, GE; Fahmy, H; Hu, Y; Kuppast, B; Liapakis, G; Lynch, C; Spyridaki, K | 1 |
1 review(s) available for thiazoles and neuropeptide y
Article | Year |
---|---|
Dipeptidyl peptidase IV: a molecular switch of vascular actions of neuropeptide Y.
Topics: Atherosclerosis; Blood Vessels; Dipeptidyl Peptidase 4; Humans; Muscle, Smooth, Vascular; Neovascularization, Physiologic; Neuropeptide Y; Pentanoic Acids; Serine Proteinase Inhibitors; Thiazoles; Thiazolidines; Vasoconstriction | 2006 |
1 trial(s) available for thiazoles and neuropeptide y
Article | Year |
---|---|
[Effect of rosiglitazone on insulin resistance and hyperandrogenism in polycystic ovary syndrome].
Topics: Administration, Oral; Adult; Androstenedione; Blood Glucose; Body Weight; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin; Insulin Resistance; Leptin; Lipids; Luteinizing Hormone; Menstruation; Neuropeptide Y; Ovulation; Polycystic Ovary Syndrome; Rosiglitazone; Testosterone; Thiazoles; Thiazolidinediones; Treatment Outcome | 2002 |
12 other study(ies) available for thiazoles and neuropeptide y
Article | Year |
---|---|
Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Benzothiazoles; Carnosine; Cognition; Cross-Linking Reagents; Fructose; Glycation End Products, Advanced; Guanidines; Humans; Memory; Neuropeptide Y; Particle Size; Peptide Fragments; Piperazines; Protein Structure, Secondary; Solubility; Temperature; Thiazoles; Thiophenes | 1997 |
Increased feeding in fatty Zucker rats by the thiazolidinedione BRL 49653 (rosiglitazone) and the possible involvement of leptin and hypothalamic neuropeptide Y.
Topics: Animals; Appetite Stimulants; Body Weight; Eating; Hyperphagia; Hypoglycemic Agents; Hypothalamus; Leptin; Male; Neuropeptide Y; Proteins; Rats; Rats, Wistar; Rats, Zucker; Rosiglitazone; Thiazoles; Thiazolidinediones | 1997 |
SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterization.
Topics: Animals; Appetite Stimulants; Callithrix; Cerebellum; Cyclic GMP; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Eating; Female; Gallbladder Emptying; Gastric Acid; Gastric Emptying; Gerbillinae; Indoles; Male; Mice; Motor Activity; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Receptors, Cholecystokinin; Species Specificity; Stereotyped Behavior; Thiazoles | 1999 |
The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability.
Topics: Administration, Oral; Animals; Binding, Competitive; Biological Availability; Brain; Carbamates; Cell Membrane; CHO Cells; Cricetinae; Feeding Behavior; Hippocampus; Humans; Inhibitory Concentration 50; Injections, Intraventricular; Male; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptors, Neuropeptide Y; Thiazoles; Time Factors | 1999 |
Aging and the neuroendocrine regulation of reproduction and body weight.
Topics: Aging; Animals; Arcuate Nucleus of Hypothalamus; Body Composition; Body Weight; Chromans; Eating; Gene Expression Regulation, Developmental; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Hypoglycemic Agents; Insulin; Leptin; Male; Models, Animal; Neuropeptide Y; Neurosecretory Systems; Pituitary Gland; Rats; Rats, Inbred BN; Reproduction; RNA, Messenger; Testis; Thiazoles; Thiazolidinediones; Troglitazone; Weight Gain | 2000 |
Insulin-sensitizing action of rosiglitazone is enhanced by preventing hyperphagia.
Topics: Animals; Body Weight; Carrier Proteins; Eating; Food Deprivation; Hyperphagia; Hypoglycemic Agents; Hypothalamus; Insulin Resistance; Ion Channels; Leptin; Male; Mitochondrial Proteins; Neuropeptide Y; Obesity; Rats; Rats, Wistar; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Uncoupling Protein 3 | 2001 |
Troglitazone treatment of aging Brown Norway rats improves food intake and weight gain after fasting without increasing hypothalamic NPY gene expression.
Topics: Aging; Animals; Body Composition; Chromans; Eating; Fasting; Gene Expression; Hypoglycemic Agents; Hypothalamus; In Situ Hybridization; Insulin; Leptin; Male; Neuropeptide Y; Protein Precursors; Rats; Rats, Inbred BN; RNA, Messenger; Thiazoles; Thiazolidinediones; Troglitazone; Weight Gain | 2002 |
Effect of neuropeptide Y on inflammatory paw edema in the rat: involvement of peripheral NPY Y1 and Y5 receptors and interaction with dipeptidyl-peptidase IV (CD26).
Topics: Animals; Arginine; Cells, Cultured; Concanavalin A; Dipeptidyl Peptidase 4; Dose-Response Relationship, Drug; Edema; Hydrogen Peroxide; Inflammation; Isoleucine; Macrophages; Male; Neuropeptide Y; Peptide Fragments; Peptide YY; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Thiazoles | 2002 |
Establishment of robust functional assays for the characterization of neuropeptide Y (NPY) receptors: identification of 3-(5-benzoyl-thiazol-2-ylamino)-benzonitrile as selective NPY type 5 receptor antagonist.
Topics: Animals; Cell Line; Dose-Response Relationship, Drug; Humans; Mice; Neuropeptide Y; Nitriles; Protein Binding; Receptors, Neuropeptide Y; Thiazoles | 2005 |
Effect of pharmacological manipulations of neuropeptide Y and corticotropin-releasing factor neurotransmission on incubation of conditioned fear.
Topics: Acoustic Stimulation; Animals; Arginine; Benzazepines; Conditioning, Operant; Corticotropin-Releasing Hormone; Fear; Male; Neuropeptide Y; Pyridazines; Rats; Rats, Long-Evans; Receptors, Corticotropin-Releasing Hormone; Receptors, Neuropeptide Y; Synaptic Transmission; Thiazoles; Time Factors | 2009 |
Dental pulp fibroblasts express neuropeptide Y Y1 receptor but not neuropeptide Y.
Topics: Blotting, Western; Cell Culture Techniques; Cell Proliferation; Cells, Cultured; Coloring Agents; Dental Caries; Dental Pulp; Fibroblasts; Humans; Interleukin-1beta; Membrane Proteins; Neuroimmunomodulation; Neuropeptide Y; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; Substance P; Tetrazolium Salts; Thiazoles; Transforming Growth Factor beta | 2010 |
Synthesis of new thiazolo[4,5-d]pyrimidines as Corticotropin releasing factor modulators.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Binding Sites; Corticotropin-Releasing Hormone; Cyclic AMP Response Element-Binding Protein; Dopamine beta-Hydroxylase; Dopamine Plasma Membrane Transport Proteins; Gene Expression; HEK293 Cells; Humans; Monoamine Oxidase; Neuropeptide Y; Protein Binding; Pyrimidines; Receptors, Corticotropin-Releasing Hormone; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Thiazoles | 2014 |